TD Cowen analyst Marc Frahm maintained a Buy rating on Shattuck Labs (STTK – Research Report) yesterday. The company’s shares ...

Australia is on the brink of a healthcare revolution driven by DNA science that will save lives and prevent disease – but top ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

TD Cowen analyst Marc Frahm has maintained their bullish stance on ACRV stock, giving a Buy rating today. Marc Frahm has given his Buy rating ...